CHRISTCHURCH, NEW ZEALAND -- (MARKET WIRE) -- October 03, 2006 -- Keratec Limited and US-based Keraplast Technologies Limited today announced the successful completion of a human clinical trial of their patented Keragen™ range of chronic wound treatment products. The results showed sufficient promise to clear the way for further more comprehensive trials.
